- Home
- MTR vs BMRA Comparison
MTR vs BMRA Comparison
Compare MTR & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTR
- BMRA
- Stock Information
- Founded
- MTR 1979
- BMRA 1971
- Country
- MTR United States
- BMRA United States
- Employees
- MTR N/A
- BMRA N/A
- Industry
- MTR Oil & Gas Production
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- MTR Energy
- BMRA Health Care
- Exchange
- MTR Nasdaq
- BMRA Nasdaq
- Market Cap
- MTR 8.6M
- BMRA 8.2M
- IPO Year
- MTR N/A
- BMRA N/A
- Fundamental
- Price
- MTR $4.58
- BMRA $2.22
- Analyst Decision
- MTR
- BMRA
- Analyst Count
- MTR 0
- BMRA 0
- Target Price
- MTR N/A
- BMRA N/A
- AVG Volume (30 Days)
- MTR 16.0K
- BMRA 23.0K
- Earning Date
- MTR 01-01-0001
- BMRA 10-14-2025
- Dividend Yield
- MTR 4.48%
- BMRA N/A
- EPS Growth
- MTR N/A
- BMRA N/A
- EPS
- MTR 0.23
- BMRA N/A
- Revenue
- MTR $623,288.00
- BMRA $4,884,000.00
- Revenue This Year
- MTR N/A
- BMRA N/A
- Revenue Next Year
- MTR N/A
- BMRA N/A
- P/E Ratio
- MTR $19.72
- BMRA N/A
- Revenue Growth
- MTR N/A
- BMRA N/A
- 52 Week Low
- MTR $4.29
- BMRA $2.08
- 52 Week High
- MTR $10.42
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- MTR 42.77
- BMRA 25.32
- Support Level
- MTR $4.50
- BMRA $2.16
- Resistance Level
- MTR $4.69
- BMRA $2.56
- Average True Range (ATR)
- MTR 0.20
- BMRA 0.12
- MACD
- MTR 0.03
- BMRA -0.04
- Stochastic Oscillator
- MTR 47.99
- BMRA 4.47
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.